- Home
- CHNR vs APVO Comparison
CHNR vs APVO Comparison
Compare CHNR & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- APVO
- Stock Information
- Founded
- CHNR N/A
- APVO 2016
- Country
- CHNR Hong Kong
- APVO United States
- Employees
- CHNR N/A
- APVO N/A
- Industry
- CHNR Precious Metals
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- APVO Health Care
- Exchange
- CHNR Nasdaq
- APVO Nasdaq
- Market Cap
- CHNR 6.1M
- APVO 5.4M
- IPO Year
- CHNR 1995
- APVO N/A
- Fundamental
- Price
- CHNR $0.57
- APVO $3.47
- Analyst Decision
- CHNR
- APVO Strong Buy
- Analyst Count
- CHNR 0
- APVO 1
- Target Price
- CHNR N/A
- APVO $296.00
- AVG Volume (30 Days)
- CHNR 43.9K
- APVO 43.1K
- Earning Date
- CHNR 01-01-0001
- APVO 03-04-2025
- Dividend Yield
- CHNR N/A
- APVO N/A
- EPS Growth
- CHNR N/A
- APVO N/A
- EPS
- CHNR N/A
- APVO N/A
- Revenue
- CHNR N/A
- APVO N/A
- Revenue This Year
- CHNR N/A
- APVO N/A
- Revenue Next Year
- CHNR N/A
- APVO N/A
- P/E Ratio
- CHNR N/A
- APVO N/A
- Revenue Growth
- CHNR N/A
- APVO N/A
- 52 Week Low
- CHNR $0.51
- APVO $3.01
- 52 Week High
- CHNR $1.43
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- CHNR 43.80
- APVO 33.42
- Support Level
- CHNR $0.55
- APVO $3.20
- Resistance Level
- CHNR $0.60
- APVO $3.65
- Average True Range (ATR)
- CHNR 0.03
- APVO 0.34
- MACD
- CHNR -0.00
- APVO 0.01
- Stochastic Oscillator
- CHNR 28.57
- APVO 31.51
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.